INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 56 filers reported holding INHIBRX INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,711 | -18.5% | 16,224 | +15.3% | 0.00% | – |
Q2 2023 | $365,205 | -18.8% | 14,068 | -41.0% | 0.00% | – |
Q1 2023 | $449,917 | +2.1% | 23,843 | +33.4% | 0.00% | – |
Q4 2022 | $440,489 | +76.2% | 17,877 | +28.7% | 0.00% | – |
Q3 2022 | $250,000 | +51.5% | 13,887 | -4.5% | 0.00% | – |
Q2 2022 | $165,000 | -89.4% | 14,538 | -79.2% | 0.00% | -100.0% |
Q1 2022 | $1,556,000 | -51.4% | 69,821 | -4.8% | 0.00% | 0.0% |
Q4 2021 | $3,203,000 | +36.2% | 73,349 | +3.9% | 0.00% | 0.0% |
Q3 2021 | $2,352,000 | +20.2% | 70,580 | -0.7% | 0.00% | 0.0% |
Q2 2021 | $1,957,000 | +1695.4% | 71,100 | +1207.0% | 0.00% | – |
Q1 2021 | $109,000 | -42.0% | 5,440 | -4.6% | 0.00% | – |
Q4 2020 | $188,000 | – | 5,701 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |